Production (Stage)
MediciNova, Inc.
MNOV
$1.41
$0.01991.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | 1.00M | 1.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | 1.00M | 1.00M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | 0.00 | 1.00M | 1.00M |
| SG&A Expenses | 5.49M | 5.48M | 5.04M | 4.95M | 5.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.74M | 12.68M | 11.98M | 10.82M | 11.07M |
| Operating Income | -12.74M | -12.68M | -11.98M | -9.82M | -10.07M |
| Income Before Tax | -11.15M | -11.04M | -10.29M | -8.16M | -8.41M |
| Income Tax Expenses | 5.50K | 5.50K | 3.00K | 3.00K | 3.00K |
| Earnings from Continuing Operations | -11.16 | -11.05 | -10.29 | -8.16 | -8.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.16M | -11.05M | -10.29M | -8.16M | -8.41M |
| EBIT | -12.74M | -12.68M | -11.98M | -9.82M | -10.07M |
| EBITDA | -12.72M | -12.65M | -11.96M | -9.80M | -10.05M |
| EPS Basic | -0.23 | -0.23 | -0.21 | -0.17 | -0.17 |
| Normalized Basic EPS | -0.14 | -0.14 | -0.13 | -0.10 | -0.11 |
| EPS Diluted | -0.23 | -0.23 | -0.21 | -0.17 | -0.18 |
| Normalized Diluted EPS | -0.14 | -0.14 | -0.13 | -0.10 | -0.11 |
| Average Basic Shares Outstanding | 196.18M | 196.18M | 196.18M | 196.18M | 196.18M |
| Average Diluted Shares Outstanding | 196.18M | 196.18M | 196.18M | 196.18M | 196.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |